Ventyx Biosciences Inc (VTYX)

Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	17.04% 41.77	50.35	57.95	57.15	42.55
Operating Income/Loss	17.04% -41.77	-50.35	-57.95	-57.15	-42.55
Nonoperating Income/Loss	11.05% 3.196	3.593	3.924	3.894	3.621
Income/Loss From Continuing Operations Before Tax	17.44% -38.57	-46.72	-54.03	-53.25	-38.93
Income/Loss From Continuing Operations After Tax	17.44% -38.57	-46.72	-54.03	-53.25	-38.93
Net Income/Loss	17.50% -38.57	-46.75	-54.03	-53.25	-38.93
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	34,288% 61.83	0.1798	58.88	58.56	57.64
Diluted Average Shares	34,288% 61.83	0.1798	58.88	58.56	57.64
Basic Earnings Per Share	21.52% -0.62	-0.79	-0.92	-0.91	-0.68
Diluted Earnings Per Share	21.52% -0.62	-0.79	-0.92	-0.91	-0.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-